A PPARγ inverse agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BAY-0069

Item No. 41525

Technical Information
Formal Name
2-bromo-N-[2-(4-ethylphenyl)-5-benzoxazolyl]-5-nitro-benzamide
CAS Number
420826-65-9
Molecular Formula
C22H16BrN3O4
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly soluble: 1-10 mg/ml
SMILES
O=C(C1=CC([N+]([O-])=O)=CC=C1Br)NC2=CC=C3OC(C4=CC=C(CC)C=C4)=NC3=C2
InChi Code
InChI=1S/C22H16BrN3O4/c1-2-13-3-5-14(6-4-13)22-25-19-11-15(7-10-20(19)30-22)24-21(27)17-12-16(26(28)29)8-9-18(17)23/h3-12H,2H2,1H3,(H,24,27)
InChi Key
BJSIVXYQIGFUCG-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    BAY-0069 is a peroxisome proliferator-activated receptor γ (PPARγ) inverse agonist.1 It acts as an inverse agonist in a co-repressor reporter assay with a peptide from nuclear receptor co-repressor 2 (NCOR2; EC50 = 9.6 nM). BAY-0069 selectively induces PPARγ- over PPARα- or PPARδ-mediated gene transcription in reporter assays using CHO cells (IC50s = 6.3, 7,500, and 9,000 nM for the human receptors, respectively). BAY-0069 inhibits the proliferation of UM-UC-9 human bladder cancer cells that endogenously contain a focal amplification of PPARG, the gene encoding PPARγ (IC50 = 2.5 nM). In vivo, BAY-0069 (75 mg/kg, i.p.) decreases intratumoral mRNA expression of the PPARγ target gene FABP4, the gene encoding fatty acid binding protein 4, in a UM-UC-9 mouse xenograft model.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Orsi, D.L., Pook, E., Bräuer, N., et alDiscovery and structure-based design of potent covalent PPARγ inverse-agonists BAY-4931 and BAY-0069. J. Med. Chem. 65(21), 14843-14863 (2022).